Replies to post #249960 on Anavex Life Sciences Corp (AVXL)

[rocalinda]

Christopher Missling: So the upcoming quarter will be the announcement of top-line data after Phase 2 Parkinson’s disease dementia study. That is really something we can put on everybody's calendar because the trial has been enrolled the last patient and we now have to wait for the 14 days – 14 weeks, which is the duration of this study plus the times needed to for the independent research zero to build the results. And then we will update the data as a – in a public announcement the top-line data, which will be mid of 2020